AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2011
May 10, 2011
33341_dirs_2011-05-10_9a1d7f74-e10d-4d20-a4ac-cc33d7ed4ee7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCI)
CIK: 0000070487
Period of Report: 2011-05-06
Reporting Person: MARTIN JOANN M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-06 | Director Stock Option (Right to Buy) | $34.55 | A | 12000 | Acquired | 2021-05-06 | Common Stock (12000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4500 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $16.94 | 2014-05-06 | Common Stock (1000) | 1000 | Direct |
| Director Stock Option (Right to Buy) | $16.05 | 2014-05-21 | Common Stock (11000) | 11000 | Direct |
| Director Stock Option (Right to Buy) | $14.20 | 2015-05-05 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $22.61 | 2016-05-04 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $25.05 | 2017-05-03 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $29.87 | 2018-05-02 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $27.23 | 2019-05-08 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $26.58 | 2020-05-07 | Common Stock (12000) | 12000 | Direct |
More from NATIONAL RESEARCH CORP
Capital/Financing Update
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Earnings Release
2026
Apr 28
Regulatory Filings
2026
Apr 20